Related Experiment Videos
Diagnostic and prognostic value of fibrin stabilising factor in Schönlein-Henoch syndrome
Insights
Fibrin stabilising factor (FSF) levels were significantly lower in children with Schönlein-Henoch syndrome, correlating with disease severity and complications. FSF determination aids in diagnosing and monitoring this vasculitis.
Area of Science:
- Pediatric Hematology
- Immunology
- Vascular Biology
Background:
- Fibrin stabilising factor (FSF) plays a crucial role in hemostasis and wound healing.
- Schönlein-Henoch syndrome is a common childhood vasculitis with potential systemic complications.
- The role of FSF in Schönlein-Henoch syndrome has not been extensively studied.
Purpose of the Study:
- To investigate FSF levels in children diagnosed with Schönlein-Henoch syndrome.
- To correlate FSF levels with disease activity, severity, and complications.
- To evaluate the diagnostic and prognostic utility of FSF determination in this condition.
Main Methods:
- Blood samples were collected from 196 children, including 131 controls, 20 with other diseases, and 45 with Schönlein-Henoch syndrome.
- Fibrin stabilising factor (FSF) activity was measured in all participants.
- Statistical analysis was performed to compare FSF levels between groups and correlate with clinical parameters.
Main Results:
- FSF levels were significantly lower in children with Schönlein-Henoch syndrome at the onset of vasculitis compared to controls.
- A decrease in FSF levels correlated with the severity of complications in affected children.
- Increasing FSF levels were associated with clinical recovery from the vasculitis.
Conclusions:
- Reduced Fibrin stabilising factor (FSF) activity is a characteristic finding in Schönlein-Henoch syndrome.
- FSF determination can serve as a valuable diagnostic marker for Schönlein-Henoch vasculitis.
- Monitoring FSF levels may help assess disease progression, predict complications, and guide therapeutic interventions.
Abstract:
Fibrin stabilising factor (FSF) was studied in the circulating blood of 196 children. These 196 children comprised three groups: 131 controls (group A), 20 children with diseases of potential repercussion on FSF determination (group B), and 45 children with Schönlein-Henoch syndrome (group C). Determinations from groups A and B produced normal values, but results from group C were significantly lower at the onset of the vasculitis. Seventeen children with Schönlein-Henoch syndrome have had complications, in 7 of whom these were severe. The decrease in FSF levels was correlated with the severity of such complications, and an increase in FSF was associated with recovery. Determination of FSF activity appears to help in the diagnosis of Schönlein-Henoch vasculitis, as well as helping to monitor the course of the disease and assessing the risks of complications.